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Glucose metabolism is difficult to image with cellular
resolution in mammalian brain tissue, particularly with
18fluorodeoxy-D-glucose (FDG) positron emission to-
mography (PET). To this end, we explored the potential
of synchrotron-based low-energy X-ray fluorescence
(LEXRF) to image the stable isotope of fluorine (F) in
phosphorylated FDG (DG-6P) at 1 lm2 spatial resolution
in 3-lm-thick brain slices. The excitation-dependent flu-
orescence F signal at 676 eV varied linearly with FDG
concentration between 0.5 and 10 mM, whereas the en-
dogenous background F signal was undetectable in
brain. To validate LEXRF mapping of fluorine, FDG was
administered in vitro and in vivo, and the fluorine LEXRF
signal from intracellular trapped FDG-6P over selected
brain areas rich in radial glia was spectrally quantitated
at 1 lm2 resolution. The subsequent generation of spatial
LEXRF maps of F reproduced the expected localization
and gradients of glucose metabolism in retinal Mu¨ller
glia. In addition, FDG uptake was localized to periventric-
ular hypothalamic tanycytes, whose morphological
features were imaged simultaneously by X-ray absorp-
tion. We conclude that the high specificity of photon
emission from F and its spatial mapping at 1 lm
resolution demonstrates the ability to identify glucose
uptake at subcellular resolution and holds remarkable
potential for imaging glucose metabolism in biological
tissue. VC 2012 Wiley Periodicals, Inc.
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Glucose metabolism is essential to brain function
because it is the predominant substrate that indirectly
supports all energy requiring activities of the mammalian
brain. Glucose’s role in maintaining brain function is
exemplified by regional increases in neuronal activity
that are correlated with increases in glucose metabolism,
implying that a rapid and effective modulation of glucose
metabolism is occurring during and following functional
responses to neural stimulation (Phelps, 2000). This cor-
relation makes 18fluorodeoxy-D-glucose (FDG) PET
imaging the gold standard in the noninvasive evaluation
of brain metabolism.
When 2-deoxy-D-glucose (DG) is used, its uptake
and subsequent phosphorylation yield 2-deoxy-D-glu-
cose-6-phosphate (DG-6P), which is trapped in the met-
abolically active cell at concentrations that can reach
micromoles per gram, detectable by nuclear magnetic
resonance (NMR; Cohen et al., 2002). Patterns of
regional DG utilization have been measured in brain
autoradiographs using either 14C or 3H (Sokoloff et al.,
1977). These methods are largely limited by the mean
free path length of b particles (Knoechel and Kalff,
1976; cf. Caro et al., 1962; Caro, 1962), so DG6P
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imaging in adult mammalian CNS is generally limited to
length scales prohibiting cellular resolution, with a few
exceptions (Ryan and Sharp, 1982; Poitry-Yamate and
Tsacopoulos, 1991; Nehlig et al., 2004). However, cen-
tral to understanding the mechanism of the tripartite
synapse, i.e., presynaptic and postsynaptic neuron as well
as glial processes (Smith, 2010), the physiological mecha-
nisms underlying in vivo 18FDG PET neuroimages
(Frackowiak et al., 2002), and the cell specificity of glu-
cose metabolism, which has not yet been completely
established (Chih et al., 2001), requires measurements at
micrometer resolution.
To image the structurally identical molecule, albeit
nonradiolabeled, i.e., 19F in FDG-6P with subcellular
spatial resolution, we explored the potential of synchro-
tron-based low-energy X-ray fluorescence (LEXRF).
With synchrotron based X-ray microspectroscopy, mi-
crometer spatial resolution is achievable (see, e.g., David
et al., 2000; Kaulich et al., 2011). X-ray fluorescence
(XRF) imaging is based on the XRF emission, unique
for each element of the periodic table, irradiated with
X-rays of sufficient energy that results in the removal of
core electrons. Therefore, the XRF spectrum contains
information on the abundance of a specific elemental
constituent in the specimen. The advantage of using a
synchrotron X-ray source is its high brightness and tuna-
bilty, so the X-ray energy can be optimized to provide
high fluorescence yield from the element under investi-
gation (Mu¨ller, 1972; Ide-Ektessabi, 2007; Ortega et al.,
2007). Use of an X-ray microprobe and scanning the
specimen allows mapping of the elemental spatial distri-
bution (Kaulich et al., 2011). This approach, however,
has not been applied to brain energy metabolism, partic-
ularly exogenous fluorine (F) in FDG, because of F’s
inherently low fluorescence yields and low interaction
cross-section and the limited penetration depth of low-
energy incident X-ray light in biological tissue (Streli
et al., 1999; Hoefler et al., 2006).
The aim of the present study was to develop and
validate the capability of synchrotron-based LEXRF to
image F in phosphorylated FDG with subcellular resolu-
tion. First, we were able to reproduce previous findings
of FDG uptake into the retina, known for its laminar
structure, allowing us to localize glucose metabolism to
radial Mu¨ller glial cells (Poitry-Yamate and Tsacopoulos,
1991). Second, to determine whether such gradients in
glucose uptake matching glial density can also be
observed in other brain regions, we assessed FDG me-
tabolism in the periventricular hypothalamus, also a
highly laminar structure, containing the radial tanycytes
that line the hypothalamus–third ventricle interface.
MATERIALS AND METHODS
All animal experiments were conducted according to
federal and local ethical guidelines, and the protocols were
approved by the local regulatory body of the Canton Vaud,
Switzerland (Service de la Consommation et des Affaires Ve´t-
e´rinaires, Affaires Ve´te´rinaires, Canton de Vaud, Suisse). All
chemicals were purchased from Sigma-Aldrich (Buchs, Swit-
zerland).
DG-6P Bioenzymatic Assay
The 1:1 stoichiometry between F and DG-6P allowed
estimating the concentration of fluorine in FDG-6P in brain
samples subsequent to FDG administration by enzymatically
converting FDG-6P back to FDG. The FDG produced in this
reaction was then assayed spectrophotometrically at 560 nm
using a previously established procedure based on Trinder’s
method (Poitry-Yamate et al., 2009). Briefly, to confirm the
activity of G6Pase to degrade DG-6P to DG, we started with
standards of D-glucose-6P. Standards were exposed to 5 U
G6Pase for 10 min (pH 7.5) at 308C with shaking. D-glucose
from these samples and D-glucose standards were then bioas-
sayed spectrophotometrically at 560 nm using glucose oxidase.
The concentration of D-glucose-6P was calculated from the
difference between the absorbance values with or without
G6Pase in the assay. Spectrophotometric measurements were
then performed using standards of DG-6P and FDG and
retinal samples that had not been frozen prior to enzymatic
measurements.
FDG Uptake Experiments
In vitro. Retinae, excised from the eyes of Sprague-
Dawley rats (300 g) anesthetized with isoflurane (4%)
followed by pentobarbital (65 mg/kg), were transferred to bi-
carbonate-buffered Ringer’s solution (BBRS) carrying 5 mM
D-glucose (378C, pH 7.4) and then light and dark adapted in
parallel (Poitry-Yamate and Tsacopoulos, 1991). After 60 min,
quarters of retinae were briefly washed to remove D-glucose
and then exposed to 10 mM FDG for 50 min. Thereafter,
metabolism was stopped and nonphorphorylated FDG
removed by washing the preparations in 3 3 600 ll chilled
BBRS.
In vivo. Three in vivo FDG experiments were per-
formed using Sprague-Dawley rats on a dedicated small-animal
APD-based PET scanner (Gamma Medica, Sherbrook,
Ontario, Canada) following a bolus delivery i.v. of 19FDG
(2 g/kg) under pentobarbital anesthesia in place of 18FDG.
18FDG PET was performed in another set of rats under iden-
tical conditions to confirm DG uptake and phosphorylation.
Tissue Fixation
For Figure 2, preparations were immersed in 4% forma-
lin in Dulbecco’s phosphate-buffered saline (DPBS). For
Figures 1 and 3, preparations were frozen flat in a custom-
made, well support immersed in isopentane, cooled in liquid
nitrogen, then lyophylized (1024 mbars). For Figure 4, 4%
formalin in chilled 0.9% NaCl was perfused through the myo-
cardial left ventricle. The animal was decapitated, and the
brain was removed and transferred to 4% formalin in DPBS.
All preparations were briefly washed in DPBS to remove
excess formalin prior to dehydration.
Planar Specimen Surfaces
Over the course of 5 days, slices of brain tissue, follow-
ing chemical fixation, were dehydrated in a series of increasing
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acetone (in percentage: 30 3 4, 50 3 4, 70 3 5, 90 3 5,
and 100 3 5, 20 min each), then infiltrated in a series of
increasing Epon (acetone:Epon 3:1, 1:1, 1:3, and 0:3) pre-
pared for maximum hardness to minimize radiation damage
(Fayard et al., 2009; Meents et al., 2010). Brain slices were
then oriented, and Epon polymerization was performed at
708C for 2 days. Tissue blocks were shaped and then sec-
tioned to 3 lm thickness on a conventional ultramicrotome,
removing undesirable topographical information at the sample
surface (Penner-Hahn, 2000).
FDG Standards for LEXRF Measurements
FDG standards equivalent to 0.5, 1, 3, 5 and 10 mM
were prepared at the Laboratory for Interdisciplinary Lithogra-
phy at ELETTRA by spin coating FDG in tetrahydrofuran
(THF) or FDG in polymethyl methacrylate (PMMA) in dime-
thylsulfoxide onto silicon nitride membrane windows. Stand-
ards were then air dried, producing a transparent membrane
film 3 lm in thickness.
Twinmic Beamline Configuration for LEXRF of F
X-ray measurements were performed at 907 eV with a
0.6-lm-diameter X-ray microprobe delivered by a 320-lm-
diameter Fresnel zone plate with an outermost zone width of
50 nm. X-ray fluorescence photon emission was detected by
four silicon drift detectors (SDDs) in an annular configuration
(Kaulich et al., 2006; Alberti et al., 2009; Gianoncelli et al.,
2009). The sample preparation was raster-scanned with respect
to the microprobe, simultaneously collecting the emitted and
transmitted photons. To characterize the morphology of the
specimen, scanning transmission X-ray microscopy (STXM)
imaging was performed in both absorption and phase-contrast
modes and acquired by a CCD camera. LEXRF map areas
ranged between 600 and 1,100 lm2 (600–1,100 pixels2), with
dwell times between 45 and 60 sec/pixel.
LEXRF Analysis
Deconvolution of the fluorescence spectrum for each
pixel was performed using the PyMCA Hypermet algorithm
and constant baseline substraction (Sole´ et al., 2007). The Ka
emissions for C, N, O, F, and elastic scattering (EO) lines were
monitored. In this article, only the fits for C, N, O, and F are
shown. To verify that the small to negligible contribution of
iron (probably below the beamline detection limits) did not
affect the fitting of F, an earlier fitting procedure included the
emission energy of Fe La (705 eV). The measured F fluores-
cence yield was 0.010, and the Fe fluorescence yield was half
that of F. The extracted peak heights for C, O, N, and F were
normalized with respect to the beam current over the course of
the LEXRF scan. To compare F photon signal intensities from
one region to another in F maps, the F photon signal was fur-
ther normalized with respect to the beam current of the first
pixel of the scan. In Figures 2–4, spectra profiles of normalized
photon counts as a function of emission energy represent the
average of four spectra taken from four individual pixels in a
2 lm 3 2 lm (2 pixel 3 2 pixel) array. The location of the
array is denoted in the absorption images (Fig. 2) or by the
numbers indicated in the LEXRF F maps (Figs. 3c, 4b).
RESULTS
To determine the amount of FDG-6P, retinal sam-
ples were analyzed by using biochemical methods
(Poitry-Yamate et al., 2009) prior to LEXRF detection
of F. Standards of known concentrations of D-glucose-
6P were first subjected to a sequential enzymatic reac-
tion using G6Pase, followed by glucose oxidase. As
Fig. 1. Bioenzymatic determination of fluorine in FDG-6P. a:
Standards of D-glucose-6P ranging from 7.8 to 500 lM were linearly
related to the concentration of D-glucose produced in the reaction
with G6Pase followed by glucose oxidase. Inset: Calibration curve
of absorbance values used to calculate D-glucose concentration. b:
Standards of FDG ranging from 0.625 to 20 mM (blue lozenges)
were linearly related to absorbance of resorufin at 560 nm in the
presence of reagent. Concentrations of FDG-6P determined from
four retinae are shown in blue. Inset: Sandards of DG-6P were line-
arly related to absorbance at 560 nm.
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shown in Figure 1a, the concentration of D-glucose pro-
duced in the enzymatic reactions varied linearly as a
function of the starting concentration of D-glucose-6P.
This enzymatic bioassay was also inherently sensitive to
FDG (Fig. 1b). The amount of F from four retinae cal-
culated from absorbance values of FDG with or without
G6Pase in the assay is shown in Figure 1b (red lozenges),
averaging 6.4 6 1.23 mM.
The emission of fluorescent photons by F is conse-
quent to the atom’s excitation with incident photons
that eject F core–shell electrons, i.e., photoelectric effect,
as illustrated in Figure 2a using the Bohr atom model
and in Figure 2b, relative to X-ray illumination of the
specimen. In this study, an incident photon flux of 2
3 1011 photons/sec/100 mA and photon energy of
907 eV (or wavelength <10 nm) was focused to a 1-
lm-diameter spot on the surface of the specimen, whose
configuration on the microscope stage is shown in Fig-
ure 2c. The incident X-ray photon energy was selec-
tively matched to the inner shell electron energies of F,
in addition to other low-Z elements of biological inter-
est, i.e., C, O, and N, thereby covering an energy range
from 200 to 1,000 eV. Under these conditions, the
number of fluorescent photons emitted at 676 eV was
determined from FDG standards. Independent of sol-
vent, F was linearly related to the concentration of F in
Fig. 2. Principles of X-ray fluorescence and detection of F in con-
trols. a:A core K-shell electron is ejected from the F atom upon X-
ray excitation by synchrotron light. The created vacancy is filled by a
higher (L) shell electron, a process that results in the emission of a
fluorescent F photon specifically at 676 eV. b: The photoelectric
effect in a relative to the biological specimen (blue) is a ‘‘photon in’’
(excitation)–‘‘photon out’’ (emission) phenomenon. The emitted
photons from F (yellow outlined red dots) are collected by energy
dispersive detectors for multielement analysis. The 1-lm-diameter
photon beam (orange) is stationary, so the sample is raster-scanned
with respect to the microprobe, simultaneously collecting the emitted
and transmitted photons. One photon-energy emission spectral map,
low energy X-ray fluorescence (LEXRF) Z elemental maps, and a
scanning transmission X-ray image (STXM) in absorption and
phase-contast mode are recorded pixel by pixel to build gradually a
complete map of the selected brain area. c: Epon-embedded brain
sections, e.g., periventricular hypothalamus shown, were mounted
onto gold electron microscopic grids previously centered over holes
in a molybdenum plate (in black). Scale: 100 lm 3 100 lm per grid
square. d: Detector response to 0.5, 1, 3, 5, and 10 mM FDG, pre-
pared using two different solvents. Measurements were performed in
triplicate (for PMMA) and quadruplicate (for THF) and expressed as
the average number of photons emitted at 676 eV 6 SEM. e:
STXM image of a retinal preparation (inner half) previously exposed
to D-glucose in place of FDG. The dashed yellow outline measures
10 lm 3 60 lm. f: Ten pixel 3 60 pixel LEXRF map of F
obtained from the area indicated in e. g: Spectral profile of Ka emis-
sion for C, N, O, F, and elastic scattering (EO) averaged from the
solid boxed area indicated in e. Note that F at 676 eV was indistin-
guishable from the detector noise. h: STXM image of the epon ma-
trix, 3 lm in thickness, overlying the gold EM grid (in focus). Inset:
Epon layer, post-LEXRF scanned, is in focus to show the 5 lm 3 5
lm (5 pixel 3 5 pixel) irradiated area. i: Averaged, normalized
energy emission spectra from the area scanned in h. Note the absence
of an F signal.
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FDG, reaching a detection limit at 0.5 mM (Fig. 2d). In
contrast, the Ka emission for F at 676 eV was indistin-
guishable from the detector noise when measured from
the Epon matrix that displaced water in the brain sam-
ples (Fig. 2h,i) and from retinae not previously exposed
to FDG (Fig. 2e,g). This result demonstrated that no F
background signal in brain tissue would complicate the
X-ray fluorescence analysis, i.e., that F detected is from
the FDG administered.
To reproduce previous experimental findings dem-
onstrating that glucose uptake in the mammalian retina
is localized predominantly to radial glia (Fig. 3a), we
measured the X-ray fluorescence F signal subsequent to
FDG uptake in five dark-adapted retinae (Fig. 3b)
known to have high excitatory synaptic transmission.
FDG-6P decreased with decreasing glial content, illus-
trated by the LEXRF F (photon) signals (Fig. 3d)
obtained from regions 1–3, resulting in a diffuse F map
(Fig. 3c) in the photoreceptor layer (PH; region 3). In
contrast, the inner synaptic layer (ISL) and Mu¨ller cell
layer (MC), rich in prominent glial endfeet (region 1 at
the vitreous–retinal interface, and perivascular in region
2), exhibited high uptake and phosphorylation of FDG,
with a clearly discernible F signal in the energy emission
spectra (Fig. 3d). The F map indicates finger-like
branching structures and large patches of F surrounding
a blood vessel (indicated by an asterisk in Fig. 3b,c).
Similarly, FDG uptake and phosphorylation from one
endfoot (EF; Fig. 3a) to another along the retinal vitre-
ous interface (parallel to the inner retinal surface) was
comparable to that of region 1 (Fig. 4). When the X-ray
fluorescence photon signal at 676 eV was plotted from
Fig. 3. Retinal glucose metabolism imaged under stimulated condi-
tions at 1 lm2 resolution. a: Morphology of a single Mu¨ller glial cell
in relation to its position in situ, scaled and oriented with respect to
b and c. b: Photomicrograph of the area adjacent to the retinal area
scanned for F. Scaled to map in c. c: LEXRF map of F in FDG-6P
from the inner (top) to outer (bottom) retinal layers. d: Spectra pro-
files of Ka emission for C, O, N, F, and elastic scattering (EO) from
regions 1–3 indicated in c. Dwell time 47 sec/pixel. e: F signal as a
function of distance from the inner limiting membrane, separating
the vitreous from the inner retinal surface. F signal is expressed as the
number of photons emitted after normalization with respect to the
beam current. MC, Mu¨ller cell endfeet layer; ISL, inner synaptic
layer; INL, inner nuclear layer; OSL, outer synaptic layer; PH,
photoreceptor soma layer; IS, inner photoreceptor segment layer;
OS, outer photoreceptor segment layer. Scale bar 5 10 lm.
Fig. 4. Glucose metabolism by Mu¨ller glial endfeet at the retinal–vitre-
ous interface. a: Photomicrograph of the retina identifying the area
scanned for F (in yellow) and individual retinal layers. Note the Mu¨ller
cell endfeet in dark blue at the top arrow. b: LEXRF map of normal-
ized F in FDG-6P, corresponding to the left half of the scanned area.
c: LEXRF map of F in FDG-6P, corresponding to the entire scanned
area. Scale bar same as in b. The dashed box highlights the area scanned
in b. d: F signal as a function of distance from the vitreous. Note that
in c and d the F signal has been expressed as the number of photons
emitted after normalization with respect to only the beam current.
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the inner retinal surface (inner limiting membrane) to
the outer retina (Fig. 3e; equivalent to plotting the F
photon signal per pixel of the LEXRF map by column),
the F gradient was shown to parallel glial cell density.
Notice the dip between 10 and 15 lm from the inner
retinal surface in Figure 3e that corresponds to the loca-
tion of a blood vessel.
To determine F uptake in the hypothalamus,
known for its laminar structure of tanycytes, leading to a
gradient in glial cell density similar to that of the retina
(see above), we infused FDG into three live animals.
After 50 min, anesthetized animals were perfused with
formalin through the myocardial left ventricle. FDG me-
tabolism, when quantitated at and distal to the hypothal-
amus–ventricle interface (Fig. 5a), showed that FDG-6P
decreased with increasing distance from the ventricle
(regions 1–3 in Fig. 5b), reaching detection limits (Fig.
5c, region 1) in areas rich in neurons (Fig. 5d). In con-
trast, FDG uptake and phosphorylation increased toward
the ventricle wall and was disproportionately high in
region 3 (Fig. 5b,c), corresponding to dense, multiple
rows of cell somata of tanycytes (Fig. 5a,e).
DISCUSSION
The present article describes for the first time the
adaptation and use of synchrotron-based LEXRF to
image a biochemical and metabolic process of major
importance, i.e., glucose metabolism by imaging F in
FDG trapped as FDG6P in brain tissue, in situ with sub-
cellular resolution. The approach was validated in the
retina, known for its laminar structure with varying cell
composition and then extended to the periventricular
hypothalamus, showing that radial glia from both regions
take up and phosphorylate glucose.
We first discuss the validation of the LEXRF fluo-
rine signal in retinal and hypothalamic preparations. We
then discuss how LEXRF detection of F might be
extended even further and how XRF imaging of DG-
6P differs from previous approaches. Finally, we discuss
the challenges encountered in specimen processing for
X-ray measurements.
To validate the application of LEXRF to brain
tissue metabolism, the uptake of FDG was measured in
the dark-adapted (metabolically active) retina, known for
its laminar structure and gradient in glucose metabolism,
ascribed predominantly to glial Mu¨ller cells (Poitry-
Yamate and Tsacopoulos, 1991). Overall, the correspon-
dence between Figure 3b and c, as well as among
regions 1–3 in Figure 3c and d, indicates a dispropor-
tionately high uptake and metabolism of glucose by
glia compared with photoreceptor neurons. As can be
seen from Figures 3c and 4b, localized, high intensities
of F matched the structural position of individual end-
feet—either facing the vitreous or apposing vessel
walls—and radial stalks of Mu¨ller glia (Fig. 3a), thereby
Fig. 5. Glucose metabolism imaged at the hypothalamus–third ven-
tricule interface. a: STXM image of the hypothalamus along the
lower lateral wall of the third ventricle (3V). b: LEXRF map of F in
FDG6P acquired from the red area outlined in a. Dwell time 45 sec/
pixel. c: Spectra profiles of Ka emission for C, N, O, F, and EO
from the three regions indicated in b. d: LEXRF map of C acquired
in parallel with that of F of the area indicated in a. The upper half of
the C map shows a high signal in the neuronal cytoplasm resulting
from water being displaced by epon, and thus generally low contrast.
e: Morphology of an individual hypothalamic radial glial cell (tany-
cyte) relative to the in situ position in a. Scale bars 5 20 lm in a; 10
lm in b,d.
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demonstrating the predominantly glial metabolism of
glucose in the retina. The high-energy metabolism of
the retina, phototransduction, and aerobic production of
lactate from glucose (Ola et al., 2006; Poitry-Yamate
and Pournaras, 2011) make this light-sensing part of the
CNS a highly specialized, if not unique, region, meta-
bolically and functionally, and do not necessarily reflect
glucose metabolism in other cerebral regions, i.e., cor-
tex, hypothalamus, hippocampus. Moreover, the
LEXRF results do not preclude oxidative ATP forma-
tion by retinal glia during net synthesis of glutamate and
glutamine, which, when blocked by anoxia (Winkler
et al., 2008) or methionine sulfoximine (Barnett et al.,
2000), suppresses the b-wave of the electroretinogram.
To extend the previous measurements in the retina
to other brain regions, we measured uptake of FDG in
the hypothalamus, focusing on the regions lining the
third ventricle (3V), known to be progressively low in
glial content, i.e., tanycytes (Fig. 5e), with increasing
distance from the 3V (Garcia et al., 2003). Interestingly,
F in FDG-6P (Fig. 5b,c) appeared to correspond to the
reported spatial distribution of glucose transporters at the
cell soma and stalks (Garcia et al., 2003), likely reflecting
the observation that free glucose content is regionally
constant (Poitry-Yamate et al., 2009) and thus trans-
porter expression matches tissue metabolic activity. Dis-
tant to the 3V, where glial content is low, F was at the
limits of detection (region 1, Fig. 5b,c), an indication
that neuronal energy metabolism may indeed depend in
this region on fuel transport from tanycytes, the prefer-
ential glucose consumers.
The methodology developed for this study is based
on soft X-ray fluorescence imaging, in which the use of
X-rays of wavelengths between 2 and 10 nm (i.e., 200–
1,000 eV), the well-defined fluorescence cross-sections,
and the high brightness of the synchrotron source allow
obtaining element-specific information in the submi-
crometer domain, down to 50 nm, depending on elemen-
tal concentration and characteristic X-ray energy. For a
low-Z element such as F, the penetration depth of the
incident photons is 2 lm; the spatial resolution achieva-
ble in-plane was thus essentially limited by the sensitivity
of the detector and dwell time. Although the latter
increases sensitivity according to the square-root law, the
number of detectors can in principle be increased. Such
increases in sensitivity would allow reducing the number
of incident photons and dwell time. This consideration
would be of great interest with regard to the data sets of
the present study, in which relatively long dwell times
were necessary to achieve reasonable photon statistics.
This compromise took into account the diffractive optics,
the photon flux, the beam in decay mode, and particularly
the number of SDDs, at the expense of a data acquisition
time of 18–20 continuous hours per specimen. Such
long acquisition times precluded LEXRF mapping of F at
multiple time points in multiple retinae to calculate rates
of retinal glucose utilization.
Two major characteristics distinguish synchrotron-
based X-ray imaging from conventional autoradiographic
techniques (Geary et al., 1985). First, XRF imaging
identifies and quantitates the signal specific to F at 676
eV and directly within the context of its cellular envi-
ronment (Figs. 3c–e, 4b,c), as opposed to b-radiation
onto emulsion films apposed to specimen sections in
autoradiography. Second, LEXRF elemental maps can
be simultaneously placed within a morphological context
by performing X-ray absorption imaging (STXM) in
parallel (Figs. 1e, 5a), which allowed us to identify cellu-
lar structures, used as landmarks. Another difference is
the nature of the isotope and its stimulus onset: as
opposed to radioisotopes, e.g., 18F, whose decay cannot
be controlled, the stable 19F isotope within the specimen
is illuminated (stimulated) by the synchrotron light beam
in a time and spatially controlled fashion, building up a
spatial F map by recording the F photon signal pixel by
pixel. Finally, as opposed to single detection using 3H,
14C, or 18F, multiple detection of elements within the
specimen using XRF is possible, whether they are
exogenous or endogenous in origin. This was illustrated
in the LEXRF map of carbon (Fig. 5d), revealing
neuronal somata distant to the 3V–hypothalamus inter-
face. The emission energy of F is next to that of
elements of biological interest, offering an attractive
potential strategy different from and beyond STXM to
characterize brain cell types and cytoarchitecture further.
Imaging 19F in 19FDG-6P in the brain can poten-
tially be performed with analytical techniques that do
not require the use of a synchrotron (for review see
Ortega et al., 2009). These techniques fall into two fam-
ilies. The first family makes use of an electron microp-
robe coupled either to an energy dispersive detector and
transmission electron microscopy (Ralle and Lutsenko,
2009) or to electron energy loss spectroscopy. The sec-
ond family makes use of a proton microprobe, coupled
to either particle-induced X-ray emission (Ortega et al.,
2005) or the backscattering of particles. An exciting
possibility is to combine a number of such analytical
methods (Carmona et al., 2008), but this has yet to be
performed with brain slices.
Because of the low-energy fluorescence emission of
F photons, the X-ray fluorescence signal from F may
potentially suffer from self-absorption artefacts, which
translates into an increased signal intensity loss from the
tissue surface to deeper levels within 3-lm-thick brain
sections. If self-absorption was a significant problem,
then we should have seen nonlinearity (Sitko, 2009;
Szczerbowska-Boruchowska, 2012) in F detection from
2–3-lm-thick layers of FDG standards. As shown in
Figure 2d, this was not the case.
Any fixation procedure will introduce artefacts
into the specimen, and morphometric changes, such as
shrinkage, may occur during fixation, dehydration, infil-
tration, and polymerization (Hayat, 1981). The choice
to use formalin as a cross-linking reagent (Ramos-Vara,
2005) was based on its qualities for fluorescence micros-
copy and short fixation times; formalin does not precipi-
tate proteins or destroy lipids and can be used for long-
term storage of biological tissue. Chemical fixation was
1056 Poitry-Yamate et al.
Journal of Neuroscience Research
performed before tissue dehydration, rather than in par-
allel, to minimize possible tissue shrinkage. Permeabiliza-
tion of cell membranes by the use of detergents, e.g.,
digitonin, saponin, Triton X, or DMSO, was not
employed in the present study. To a first approximation,
we assessed the quality of the fixed preparations, e.g.,
hypothalamus, by comparing the STXM images (Fig. 5a)
with confocal images of glucose transporter and GFAP
(glial) staining of tanycytes at the hypothalamus–3V
interface (see Figs. 3 and 4 in Garcia et al., 2003).
Measurements at the experimental X-ray beamline
currently require the removal of tissue water. Conse-
quently, a challenge common to performing histochem-
istry and autoradiography of biological tissue was prob-
ably encountered in this study: the conversion of a solu-
ble constituent of the cell, such as DG-6P, into an
insoluble derivative. Retaining FDG-6P in the tissue
without degrading morphology were both objectives.
However, because nonphosphorylated FDG was
expressly removed by washing and/or left ventricle infu-
sion immediately after the metabolic experiment, the
unfortunate side effect was that some FDG-6P was
inevitably lost in this process (see, e.g., Sokoloff et al.,
1977; Nehlig et al., 2004) prior to LEXRF detection of
F. This loss would be of major importance only if it
occurred in a cell-specific manner, e.g., as suggested by
the demonstration of mRNA for aralar in freshly isolated
astrocytes (Lovatt et al., 2007) and its absence in synap-
tosomal-free brain mitochondria (Berkich et al., 2007).
With regard to the two regions selected for the present
study, spatial LEXRF mapping of 19FDG-6P in brain
areas closely resembling the general cerebral architecture
are underway as part of a separate study. The preliminary
results suggest FDG uptake and phosphorylation into
neuronal cell bodies, which renders the possibility of
FDG-6P loss uniquely from neurons unlikely.
With regard to the known rates of glucose utiliza-
tion in the retina, derived from the formation of tritiated
water from [5-3H]glucose (25 nmol/min/mg protein;
Ola et al., 2006) or 2-[6-13C]deoxyglucose and 13C-
NMR spectroscopy (0.6 lmol/min/g; Cohen et al.,
2002), one could derive a` priori the rate of global glu-
cose utilization in the rat retina using dynamic 18FDG
PET imaging. However, two factors limit the success of
such measurements. 1) Unlike the case for cerebral
regions, the spatial resolution as a result of positron dif-
fusion (1 mm) exceeds the thickness of the retina. 2)
Spill-in of metabolized 18FDG from the Harderian
glands occurs. Alternatively, compartmentation of retinal
glucose metabolism and rates of change of retinal 19FDG
could be determined as described for cerebral regions by
McDougal et al. (1990). However, such measurements
are incapable of providing information by cell type.
LEXRF imaging of specimens in vitro is presently
limited for four reasons: First, in the case of hydrated
and unfixed preparations at room temperature, the
required imaging dose of radiation is much higher for
low-Z elements, i.e., C, O, N, and F, than it is for
high-Z elements (Fayard et al., 2009), and the issue
becomes collecting the fluorescence signal on a time
scale that is significantly shorter than the time scale of
potentially induced biological damage. Second, and
more important, incident X-ray photons upon absorp-
tion in aqueous biological specimens result in water mol-
ecules being ionized, producing free radicals. Third,
there is possible dehydration of the specimen. Fourth,
X-rays in the photon energy range used in the present
study have limited penetration (less than the thickness of
a single cell), limiting the potential interest in performing
LEXRF measurements with hydrated specimens.
We conclude that LEXRF is a novel and comple-
mentary imaging approach for studying brain metabolism
in situ and that glucose metabolism is largely glial in ret-
ina and periventricular hypothalamus. Coupled to the
subcellular resolution capabilities and the quantitative na-
ture of elemental detection, synchrotron-based LEXRF
and STXM together hold remarkable potential for assess-
ing FDG metabolism in regions more closely resembling
the general cerebral cytoarchitecture of mature brain.
The validation of this imaging modality in the light-
sensing and glucose-sensing regions of the CNS demon-
strates a high glycolytic activity of radial glia.
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